Class 2 Medicines Recall: Oxylan 40mg prolonged-release tablets (G.L. Pharma)

Class 2 Medicines Recall: Oxylan 40mg prolonged-release tablets (G.L. Pharma)

September 1, 2020

Class 2 MHRA medicines recall – Oxylan 40mg prolonged-release tablets (G.L.Pharma)

Drug alert number: EL (20) A/41

Date issued: 01 September 2020

The Medicines and Health products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:

Oxylan 40mg prolonged-release tablets (G.L.Pharma) PL 21597/0064 Batch 9F119A

GL Pharma is recalling the above batch of Oxylan 40mg prolonged-release tablets due to out of specification results for dissolution obtained during routine stability testing.

Advice for healthcare professionals

  • Stop supplying the above batch immediately and remove from the shelves within your pharmacy. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process

Full drug alert can be viewed here.

Company contacts for further information

For medical information enquiries please contact pv@gl-pharma.at

For stock control enquiries please contact david.hammond@healthcarepharma.co.uk

 



Posted in:


More Latest News >

PQS: AMS virtual event now on-demand

Community pharmacy contractors can now access an online recording of the antimicrobial stewardship (AMS) virtual event, which was jointly hosted...

Evaluation of LFD tests

As part of meeting Medicines and Healthcare products Regulatory Agency (MHRA) obligations, the UK Health Security Agency (UKHSA) – of...